MLA 0.00% 8.5¢ medical australia limited

Interestingly Analytica (ALT ASX; developers of the Autostart...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 798 Posts.
    lightbulb Created with Sketch. 10
    Interestingly Analytica (ALT ASX; developers of the Autostart Burette) are in a bit of difficulty. They are facing down the barrel of further significant dilution of the share register, a plummeting SP, and working capital that will likely run dry in the next quarter, combined with a disgruntled shareholder base facing potentially a considerable loss of investment.

    I wonder whether MLA who have held (and I believe still hold) distribution rights to the burette, might consider a low-ball offer for the IP of the burette? ALT seem to have focused entirely on their Pericoach device in recent times and might look favourably on any small injection of capital a bonus to keep them afloat and peddling their 'premier' device whilst also (and importantly) paying management's salaries a little bit longer!

    It would assume the burette can be sold in good numbers, which is a bit of an assumption as we haven't had any breakdown of sales or contracts, and MLA have had this product in their stable for sometime, so perhaps, it isn't marketable? Also, that MLA has the cash available & ALT are willing to offload.

    I recall Groberts mentioning an impressive demo at the AGM, involving the burette and the development staff - I'd guess from ALT? So could be worth considering if at the right price.

    DYOR, IMO etc...
 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.